Biocon Biologics Refreshes Management

Follows Departure Of Christine Hamacher As CEO

 
• By Dave Wallace

Biocon has made two key appointments to the management team of Biocon Biologics following a recent change in CEO for the biosimilars business.

Management team meeting
Biocon Biologics has bolstered its management team with two new appointments • Source: Shutterstock

More from Leadership

More from Generics Bulletin